Oladapo Yeku, Ph.D.
Affiliations: | 2010 | Molecular and Cellular Pharmacology | Stony Brook University, Stony Brook, NY, United States |
Google:
"Oladapo Yeku"Parents
Sign in to add mentor| Michael Frohman | grad student | 2010 | SUNY Stony Brook | |
| (The role of phospholipase D2 in golgi-architecture maintenance, vesicular trafficking and glucose-stimulated insulin release & validation of a novel non-invasive approach to functional beta-cell mass quantification.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Spriggs D, O’Cearbhaill R, Yeku O, et al. (2018) Abstract IA25: Strategies for glycosylation-based immunotargeting of MUC16 Clinical Cancer Research. 24 |
| Huang P, Yeku O, Zong H, et al. (2011) Phosphatidylinositol-4-phosphate-5-kinase alpha deficiency alters dynamics of glucose-stimulated insulin release to improve glucohomeostasis and decrease obesity in mice. Diabetes. 60: 454-63 |
| Yeku O, Frohman MA. (2011) Rapid amplification of cDNA ends (RACE). Methods in Molecular Biology (Clifton, N.J.). 703: 107-22 |
| Dall'Armi C, Hurtado-Lorenzo A, Tian H, et al. (2010) The phospholipase D1 pathway modulates macroautophagy. Nature Communications. 1: 142 |
| Yeku O, Scotto-Lavino E, Frohman MA. (2009) Identification of alternative transcripts using rapid amplification of cDNA ends (RACE). Methods in Molecular Biology (Clifton, N.J.). 590: 279-94 |
| Su W, Yeku O, Olepu S, et al. (2009) 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Molecular Pharmacology. 75: 437-46 |